KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Travere Therapeutics (TVTX) Return on Assets (2016 - 2025)

Historic Return on Assets for Travere Therapeutics (TVTX) over the last 17 years, with Q3 2025 value amounting to 0.0%.

  • Travere Therapeutics' Return on Assets changed 0.0% to 0.0% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.0%, marking a year-over-year change of 0.0%. This contributed to the annual value of 0.0% for FY2024, which is 3600.0% down from last year.
  • Travere Therapeutics' Return on Assets amounted to 0.0% in Q3 2025, which was down 0.0% from 0.0% recorded in Q2 2025.
  • Over the past 5 years, Travere Therapeutics' Return on Assets peaked at 0.39% during Q2 2024, and registered a low of 0.33% during Q3 2021.
  • Moreover, its 5-year median value for Return on Assets was 0.0% (2025), whereas its average is 0.0%.
  • Its Return on Assets has fluctuated over the past 5 years, first skyrocketed by 4400bps in 2023, then crashed by -3900bps in 2025.
  • Travere Therapeutics' Return on Assets (Quarter) stood at 0.28% in 2021, then skyrocketed by 127bps to 0.08% in 2022, then surged by 331bps to 0.33% in 2023, then plummeted by -101bps to 0.0% in 2024, then skyrocketed by 100bps to 0.0% in 2025.
  • Its Return on Assets was 0.0% in Q3 2025, compared to 0.0% in Q2 2025 and 0.0% in Q1 2025.